首頁 › 狼瘡性腎炎 › 紐約州 › New York City
New York City, NY 的 狼瘡性腎炎 臨床試驗
10 項針對 狼瘡性腎炎 的研究正在 New York City(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
VIBRANT: VIB4920 for Active Lupus Nephritis
招募中2 期
- Hospital for Special Surgery, New York: Division of Rheumatology, New York
- Columbia University Medical Center: Department of Medicine, Division of Rheumatology, New York
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
招募中2 期
- Hospital for Special Surgery, New York
- Children's Hospital at Montefiore, New York
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
招募中1/2 期
- Research Site, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
招募中1 期
- Icahn School of Medicine at Mount Sinai, New York
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
招募中2 期
- Icahn School of Medicine at Mount Sinai, New York
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
招募中1/2 期
- Nkarta Investigational Site, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
招募中1 期
- Montefiore Medical Center, New York
Lupus Landmark Study: A Prospective Registry and Biorepository
招募中觀察性研究
- Columbia University Medical Center, New York
- Northwell Health, New York
Safety and Efficacy of ONT01 in Lupus
招募中早期第 1 期
- Hospital for Special Surgery, New York
Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
招募中觀察性研究
- The Rogosin Institute, New York
其他城市的 狼瘡性腎炎 試驗
- Atlanta, GA9 項研究
- Chicago, IL9 項研究
- Houston, TX8 項研究
- Durham, NC8 項研究
- San Francisco, CA7 項研究
- Philadelphia, PA7 項研究
- Boston, MA7 項研究
- Miami, FL5 項研究
- Aurora, CO5 項研究
- St. Louis, MO5 項研究
- Dallas, TX4 項研究
- Charleston, SC4 項研究
New York City 的其他研究
- 乳癌136 項研究
- 非小細胞肺癌121 項研究
- 癌症(所有類型)109 項研究
- 前列腺癌103 項研究
- 轉移性癌症93 項研究
- 大腸直腸癌78 項研究
- 卵巢癌69 項研究
- 肺癌60 項研究
- 多發性骨髓瘤60 項研究
- 胰臟癌60 項研究
- 子宮內膜癌52 項研究
- 急性髓系白血病51 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月6日。各研究自行設定資格標準;由研究團隊決定參與者資格。